HES
49
2
BDX
59
3
SYK
50
4
CRM
65
6
JWN
72
9
KLAC
45
3
PNC
48
6
MMC
46
5
LUV
45
3
EXPD
29
2
GD
42
4
ADI
54
4
MSI
52
3
SRE
37
9
NWSA
69
4
MPC
28
3
AIG
38
5
ROST
60
3
DOV
48
2
FOX
71
3
HES
49
2
BDX
59
3
SYK
50
4
CRM
65
6
JWN
72
9
KLAC
45
3
PNC
48
6
MMC
46
5
LUV
45
3
EXPD
29
2
GD
42
4
ADI
54
4
MSI
52
3
SRE
37
9
NWSA
69
4
MPC
28
3
AIG
38
5
ROST
60
3
DOV
48
2
FOX
71
3
Financhill
Back

Aptevo Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
27

APVO
Aptevo Therapeutics

Last Price:
$4.36
Seasonality Move:
-31.63%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
27
Aptevo Therapeutics (APVO) is a Sell

Is Aptevo Therapeutics a Buy, Sell or Hold?

  • The current Aptevo Therapeutics [APVO] share price is $4.36. The Score for APVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APVO Stock Price Chart

What is Aptevo Therapeutics's stock price today?

  • The Aptevo Therapeutics share price today is $4.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

APVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: -43529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.66 - 11.16) Sell
Bollinger Bands (100): (6.54 - 13.42) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

APVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.12 Sell
20-day SMA: 8.24 Sell
50-day SMA: 8.71 Sell
200-day SMA: 32.53 Sell
8-day EMA: 5.29 Sell
20-day EMA: 7.09 Sell
50-day EMA: 8.69 Sell
200-day EMA: 168.98 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Aptevo Therapeutics Earnings Growth & APVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Aptevo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):